SEC Approves NYSE American $5M Minimum Market Capitalization Continued Listing Standard

New rule requires immediate trading suspension and delisting proceedings after 30 consecutive trading days below a $5 million average market capitalization

The Securities and Exchange Commission (the “SEC” or “Commission”) issued an order on Friday, November 13, Release No. 34-106893, approving NYSE American LLC’s (“NYSE American” or the “Exchange”) rule change to amend Sections 1003 and 1009 of the NYSE American Company Guide (the “Company Guide”).

The amendments establish a new continued listing requirement pursuant to which a listed company whose common stock has an average market capitalization of less than $5 million over a consecutive 30 trading-day period (the “Minimum Market Capitalization Criteria”) will be immediately suspended from trading and subject to delisting proceedings. Affected companies will not be eligible for any cure period under the Company Guide.

The Commission issued approval following an extended review period and proceedings in which the SEC received comment letters both supporting and opposing the proposal. The rule is effective as of Monday, November 16.

Key Elements of the New Rule

New Section 1003(b)(i)(D) of the Company Guide provides that if an issuer’s common stock has an average market capitalization of less than $5 million over a consecutive 30 trading-day period, the Exchange will immediately suspend trading and commence delisting proceedings. For purposes of the rule, market capitalization includes total common stock outstanding, excluding treasury shares, and any common stock issuable on conversion of another outstanding equity security that is a “substantial equivalent” of common stock.

Section 1009 is now amended to add the new standard to the list of continued listing deficiencies that do not entitle an issuer to a compliance period.

Issuers retain the right to appeal a delisting decision under Part 12 of the Company Guide, before a Listing Qualifications Panel, the Committee for Review or the Exchange Board of Directors. Those bodies may consider, among other issues, the issuer’s stock price and its public disclosures, including other quantitative deficiencies.

The Exchange states that it proactively engages with companies whose average market capitalization falls below $15 million over 30 trading days, so companies should receive meaningful advance notice before they fall below the new threshold.

The SEC’s Rationale

The Commission found the rule consistent with the Securities Exchange Act of 1934. The Commission relied on its own analysis of Nasdaq and NYSE American data from 2006 to 2025. That analysis showed that 59% of issuers which fell below the $5 million threshold remained below the threshold 180 days later. The Commission also accepted the argument that smaller-capitalization securities may be more susceptible to manipulation, including “pump and dump” and “ramp and dump” schemes.

The Commission rejected commenter arguments that the rule would delist companies because of temporary market or sector volatility, create a “cliff effect” or invite short-selling pressure designed to push an issuer below the threshold. The Commission also stated that it lacks authority to adopt commenter alternatives that were not part of the Exchange’s proposal, such as a graduated framework, a cure period or a twelve-month implementation delay.

Practical Implications for Smaller Public Companies

Since no cure period is available, the 30 trading-day measurement window is a company’s only opportunity to act. Companies near the $5 million threshold should track their rolling 30 trading-day average market capitalization, calculated under the Company Guide definition, and set internal escalation triggers well above $5 million so that the board, management and advisers are engaged early, particularly when the Exchange begins engagement at the $15 million level.

Companies cannot rely on reverse stock splits. The order emphasizes that a reverse stock split increases share price but does not directly change market capitalization. A split may help with price-based standards, but it will not cure a market capitalization deficiency.

Contingency planning should address potential over-the-counter trading, which commenters noted typically brings reduced liquidity, wider spreads, lower institutional participation and fewer financing opportunities. It should also address listing-related covenants and contractual provisions; disclosure obligations; and communications with investors, lenders and counterparties. Companies should also be aware that a parallel Nasdaq MVLS proposal is pending before the Commission, so moving to another exchange may not be a reliable alternative.

Takeaway

The new Minimum Market Capitalization Criteria are a significant tightening of NYSE American’s continued listing standards for microcap issuers. Once a company’s 30-day trading average falls below $5 million, trading will be suspended and delisting proceedings will begin, with no cure period. NYSE American-listed companies with low or declining market capitalizations should put monitoring procedures and contingency plans in place now. Our team is available to advise on compliance planning and capital-raising alternatives.